Skip to main content

Table 1 Description of baseline survey data. The study sites are given with the baseline sample size and microfilariae (mf) prevalence (%), blood volumes collected during the survey to test for mf positivity, annual biting rate (ABR) of vector mosquitoes, dominant vector species and drug regimen used for simulating the chemotherapeutic interventions by mass drug administration (MDA) without/with vector control (VC)

From: Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis

Study villages

Sample size

Blood volume (μl)

aMf (%)

bBaseline ABR

Mosquito species (genus)

cDrug regimen

dDrug efficacies (ω, ε, P)

Source

Peneng

63

1,000

66.67

8,194

An

DEC + ALB

(55, 95, 6)

[8, 11, 78, 79]

Albulum

50

1,000

80

42,328

An

DEC + ALB

(55, 95, 6)

[8, 11, 78, 79]

Yauatong

131

1,000

92.37

37,052

An

DEC + ALB

(55, 95, 6)

[8, 11, 78, 79]

Nanaha

211

1,000

54.98

11,611

An

DEC + ALB

(55, 95, 6)

[8, 11, 78, 79]

Ngahmbule

346

1,000

51.16

4,346

An

DEC + ALB

(55, 95, 6)

[8, 11, 78, 79]

Masaika

848

100

28.61

6,184

An

IVM + ALB

(35, 99, 9)

[80]

Tawalani

367

100

35.72

12,850

An

IVM + ALB

(35, 99, 9)

[16]

Jaribuni

1,007

100

25.35

15,677

An

IVM + ALB

(35, 99, 9)

[81, 82]

Tingrela

699

20

63.89

4,156

An

IVM + ALB

(35, 99, 9)

[83]

Chiconi

245

20

58.90

10,586

An

IVM + ALB

(35, 99, 9)

[84]

Kingwede

825

100

3.07

1,548

Cx

IVM + ALB

(35, 99, 9)

[80]

Mao

546

100

27.8

25,439

Cx

IVM + ALB

(35, 99, 9)

[16]

Mambrui

787

100

24.99

4,964

Cx

IVM + ALB

(35, 99, 9)

[81, 82]

Pondicherry

1,549

20

34.74

88,500

Cx

DEC + ALB

(55, 95, 6)

[85]

Calcutta

861

20

26.72

115,942

Cx

DEC + ALB

(55, 95, 6)

[86, 87]

Vettavallam

7,976

20

22.83

100,375

Cx

DEC + ALB

(55, 95, 6)

[88]

Pakistan

1,443

20

31.49

1,607

Cx

DEC + ALB

(55, 95, 6)

[89, 90]

Jakarta

922

20

12.27

223,000

Cx

DEC + ALB

(55, 95, 6)

[91]

  1. aAll mf prevalence values were standardized to reflect sampling of 1 ml blood volumes using a transformation factor of 1.95 and 1.15, respectively, for values originally estimated using 20 or 100 μl blood volumes [49]; bbaseline ABR can be used to get monthly biting rate (MBR = ABR/12); cthe combination drug regimens are recommended by the WHO [92, 93]; dthe drug efficacy values are taken from [36]. An, Anopheles mosquitoes; Cx, Culex mosquitoes; drug efficacies (ω, ε, P) (instantaneous kill rate (%) for adult worms, instantaneous kill rate (%) for microfilariae, drug efficacy period in months); mf (%), microfilariae prevalence in percentages calculated from the number of mf-positive samples out of the total individuals sampled (sample size) in a study site. ALB, albendazole; DEC, diethylcarbamazine citrate; IVM, ivermectin